Clinical Resources

Literature References

Articles

Literature References

  1. Abrams EM, Atkinson AR, Wong T, Ben-Shoshan, M. The importance of delabeling β-lactam allergy in children. J Pediatr 2019;204:291-297.
  2. Caubet J-C, Kaiser L, Lemaître B, et al. The role of penicillin in benign skin rashes in childhood: A prospective study based on drug rechallenge. J Allergy Clin Immunol 2011;127:218-222.
  3. Sade K, Holtzer I, Levo Y, Kivity, S. The economic bur- den of antibiotic treatment of penicillin-allergic pa- tients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 2003;33:501-506.
  4. Wright AJ. The penicillins. Mayo Clin Proc 1999;74: 290-307.
  5. Vergison A, Dagan R, Arguedas A, et al. Otitis media and its consequences: Beyond the earache. Lancet In- fect Dis 2010;10:195-203.
  6. Abrams EM, Wakeman A, Gerstner TV, et al. Prevalence of beta-lactam allergy: A retrospective chart review of drug allergy assessment in a predominantly pediatric population. Allergy Asthma Clin Immunol 2016;12:4-9. https://doi.org/10.1186/s13223-016-0165-6
  7. Mill C, Primeau M-N, Medoff E, et al. Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and non- immediate reactions to amoxicillin in children. JAMA Pediatr 2016;170:e160033.
  8. Vyles D, Adams J, Chiu, A, et al. Allergy testing in chil- dren with low-risk penicillin allergy symptoms. Pedi- atrics 2017;140;e20170471.
  9. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; Ameri- can College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: An updated practice parameter. Ann Allergy Asthma Immunol 2010;105:259-273.
  10. Norton AE, Konvinse K, Phillips EJ, Broyles, AD. Antibi- otic allergy in pediatrics. Pediatrics 2018;141:e20172497.
  11. LangDM,CastellsMC,KhanDA,etal.PenicillinAllergy in Antibiotic Resistance Workgroup. Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. J Allergy Clin Immunol Pract 2017;5:333-334.
  12. SolenskyR.Allergytoβ-lactamantibiotics.JAllergyClin Immunol 2012;130:1442-2.e5. https://doi.org/10.1016/j.jaci.2012.08.021
  13. KhanDA,SolenskyR.Drugallergy.JAllergyClinImmunol 2010;125:126-137.
  14. MacyE,ContrerasR.Healthcare use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: A cohort study. J Allergy Clin Immunol 2014;133:790-796.
  15. Rimawi RH, Cook PP, Gooch M, et al. The impact of penicillin skin testing on clinical practice and antimi- crobial stewardship. J Hosp Med 2013;8:341-345.
  16. Solensky R. Penicillin allergy as a public health mea- sure. J Allergy Clin Immunol 2014;133:797-798.
  17. Xie H, Chen H, Hu Y, et al. Clindamycin-induced acute kidney injury: Large biopsy case series. Am J Nephrol 2013;38:179-183.
  18. Iammatteo M, Alvarez Arango S, Ferastraoaru D, et al. Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract 2019;7:236-243.
  19. Le Saux N. Position statement: Antimicrobial stewardship in daily practice: Managing an important re- source. Canadian Paediatric Society; 2020. www.cps .ca/documents/position/antimicrobial-stewardship.
  20. Wong T, Atkinson A, t’Jong G, et al. Practice point: Beta- lactam allergy in the paediatric population. Canadian Paediatric Society; 2020. www.cps.ca/documents/ position/beta-lactam-allergy.
  21. Choosing Wisely Canada. Infectious disease. Five things physicians and patients should question in infectious disease. Accessed 1 June 2020. https://choosingwisely canada.org/infectious-disease.
  22. Choosing Wisely. American Academy of Allergy, Asthma & Immunology: Ten things physicians and patients should question. Accessed 1 June 2020. www.choosingwisely.org/societies/american -academy-of-allergy-asthma-immunology.
  23. White House Office of the Press Secretary. National Action Plan for combating antibiotic-resistant bac- teria. March 2015. Accessed 1 June 2020. www.cdc .gov/drugresistance/pdf/national_action_plan_for _combating_antibotic-resistant_bacteria.pdf.
  24. Gomes ER, Brockow K, Kuyucu S, et al. Drug hyper- sensitivity in children: Report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 2016;71:149-161.
  25. VezirE,MisirliogluED,CivelekE,etal.Directoralprovo- cation tests in non-immediate mild cutaneous reac- tions related to beta-lactam antibiotics. Pediatr Allergy Immunol 2016;27:50-54.
  26. ArnoldA,SommerfieldA,RamgolamA,etal.Theroleof skin testing and extended antibiotic courses in assess- ment of children with penicillin allergy: An Australian experience. J Paediatr Child Health 2019;55:428-432.
  27. Marrs T, Fox AT, Lack G, du Toit G. The diagnosis and management of antibiotic allergy in children: System- atic review to inform a contemporary approach. Arch Dis Child 2015;100:583-588.
  28. Mattheij M, de Vries E. A suspicion of antibiotic allergy in children is often incorrect. J Allergy Clin Immunol 2012;129:583.
  29. Chambel M, Martins P, Silva I, et al. Drug provocation tests to betalactam antibiotics: Experience in a paedi- atric setting. Allergol Immunopathol 2010;38:300-306.
  30. Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126:477-480.
  31. Mori F, Cianferoni A, Barni S, et al. Amoxicillin allergy in children: Five-day drug provocation test in the di- agnosis of nonimmediate reactions. J Allergy Clin Im- munol Pract 2015;3:375-380.
  32. Blumenthal KG, Shenoy ES, Varughese CA, et al. Impact of a clinical guideline for prescribing antibiotics to in- patients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol 2015;115:294-300.e2.
  33. Vyles D, Chiu A, Routes J, et al. Antibiotic use after removal of penicillin allergy label. Pediatrics 2018; 141:e20173466.
  34. Picard M, Paradis L, Nguyen M, et al. Outpatient peni- cillin use after negative skin testing and drug chal- lenge in a pediatric population. Allergy Asthma Proc 2012;33:160-164.
  35. Kaufman DW, Kelly, JP. Risk of anaphylaxis in a hospi- tal population in relation to the use of various drugs: An international study. Pharmacoepidemiol Drug Saf 2003;12:195-202.
  36. Heckbert SR, Stryker WS, Coltin KL, et al. Serum sickness in children after antibiotic exposure: Estimates of oc- currence and morbidity in a health maintenance orga- nization population. Am J Epidemiol 1990;132:336-342.
  37. Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: The reactive metabolite syndromes. Lancet 2000;356:1587-1591.
  38. Wallace DV. Anaphylaxis in the allergist’s office: Pre- paring your office and staff for medical emergen- cies. Allergy Asthma Proc 2013;34:120-131. https://doi .org/10.1016/j.jaci.2009.10.028
  39. Simons FER, Ardusso LRF, Bilò MB, et al. World aller- gy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011;4:13-37.
  40. DermNet NZ. Exanthems. Accessed 26 July 2020. https:// dermnetnz.org/topics/exanthems.

drop the label.

Drop the label is a multidisciplinary group of allergists, pediatricians, pharmacists, family physicians, and other healthcare providers based out of British Columbia. We promote education and tools to support prescribers serving people with potential antibiotic allergies.

Navigation
About UsPatient ToolProvider Tool
Developed in Collaboration